Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dario Health Corp (DRIO)

Dario Health Corp (DRIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,549
  • Shares Outstanding, K 7,300
  • Annual Sales, $ 22,360 K
  • Annual Income, $ -41,710 K
  • EBIT $ -37 M
  • EBITDA $ -34 M
  • 60-Month Beta 1.08
  • Price/Sales 2.67
  • Price/Cash Flow N/A
  • Price/Book 0.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-1.20
  • Number of Estimates 2
  • High Estimate $-1.09
  • Low Estimate $-1.31
  • Prior Year $-2.80
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.37 +8.82%
on 03/24/26
11.61 -30.92%
on 03/02/26
-3.95 (-33.00%)
since 02/27/26
3-Month
7.37 +8.82%
on 03/24/26
13.65 -41.22%
on 01/06/26
-2.02 (-20.12%)
since 12/26/25
52-Week
5.93 +35.13%
on 09/16/25
17.74 -54.80%
on 10/01/25
-4.44 (-35.63%)
since 03/28/25

Most Recent Stories

More News
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

NEW YORK , March 19, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced its financial results for...

DRIO : 8.02 (-2.08%)
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026

Company to host conference call and webcast at 8:30 a.m. Eastern Time

DRIO : 8.02 (-2.08%)
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health

Findings reinforce that engagement data provide clinical signals directly impacting ROI

DRIO : 8.02 (-2.08%)
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management

As oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectable formulations, Dario integrates structured behavioral reinforcement to optimize real-world success

DRIO : 8.02 (-2.08%)
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms

Growing body of peer-reviewed publications and rigorously reviewed conference research reinforces Dario's position as trusted partner for organizations seeking to reduce cost, improve outcomes and simplify...

DRIO : 8.02 (-2.08%)
Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members

First in-market activation of Dario's GenAI roadmap lays clinical and technical foundation for a seamless, conversational AI experience across the entire Dario platform

DRIO : 8.02 (-2.08%)
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio

Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudges on hypertension outcomes

DRIO : 8.02 (-2.08%)
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date

34 new employer clients added in the past two weeks expected to contribute to H1 2026 revenue

DRIO : 8.02 (-2.08%)
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year

Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual care

DRIO : 8.02 (-2.08%)
DarioHealth Reports Third Quarter 2025 Financial and Operating Results

NEW YORK , Nov. 13, 2025 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced financial results for the...

DRIO : 8.02 (-2.08%)

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

3rd Resistance Point 8.82
2nd Resistance Point 8.66
1st Resistance Point 8.34
Last Price 8.02
1st Support Level 7.86
2nd Support Level 7.70
3rd Support Level 7.38

See More

52-Week High 17.74
Fibonacci 61.8% 13.23
Fibonacci 50% 11.84
Fibonacci 38.2% 10.45
Last Price 8.02
52-Week Low 5.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.